Manuscripts
Showing 1566 manuscripts.
Interruption Of Materno-Fetal Transmission
Citation
Mofenson LM, Fowler MG. Interruption Of Materno-Fetal Transmission. AIDS. 1999. 13: S205-14. PMID: 10885777Year
1999
Journal
AIDS
Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children
Citation
Stevens RC, Frenkel LM, Rodman JH. Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children. Pharmacotherapy. 1999. 19: 487.Year
1999
Journal
Pharmacotherapy
Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter)
Citation
Shapiro DE, Sperling RS, Coombs RW. Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter). Lancet. 1999. 354: 156.Year
1999
Journal
Lancet
The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1
Citation
GD McSherry, David E. Shapiro, RW Coombs, N Mcgrath, LM Frenkel, Britto P, M Culnane, RS Sperling. The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1. Journal of Pediatrics. 1999. 134: 717-24.Year
1999
Journal
Journal of Pediatrics
Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies
Citation
Mark Mirochnick, Edmund Capparelli, James Connor. Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies. Clinical Pharmacology & Therapeutics. 1999. 66: 16-24.Year
1999
Journal
Clinical Pharmacology & Therapeutics
Lack of tumors in infants with perinantal HIV-1 exposure and fetal/neonatal exposure to zidovudine.
Citation
I. Celine Hanson, Tracy A. Antonelli, Rhoda S. Sperling, James M. Oleske, Ellen Rae Cooper, Mary Culnane, Mary Glenn Fowler, Leslie A. Kalish, Sophia S. Lee, George McSherry, Lynne Mofenson, David E. Shapiro. Lack of tumors in infants with perinantal HIV-1 exposure and fetal/neonatal exposure to zidovudine.. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999. 20: 463-467.Year
1999
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Late Effects Of In Utero Exposure To Zidovudine Among Uninfected Infants Born To HIV-Infected Women
Citation
Mary Culnane, Bethann Cunningham-Schrader, James M. Oleske, Mary Glenn Fowler, Sophia S. Lee, George D. McSherry, Michael T. Brady, Karen J. O'Donnell, Lynne M. Mofenson, Steven Gortmaker, David E. Shapiro. Late Effects Of In Utero Exposure To Zidovudine Among Uninfected Infants Born To HIV-Infected Women. The Journal of the American Medical Association. 1999. 281: 151-57.Year
1999
Journal
The Journal of the American Medical Association
Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors In Children Infected With Human Immunodeficiency Virus Type-1
Citation
Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, Florence H. Yong, Terence Fenton, Richard C. Brundage, Douglas Manion, Nancy M. Ruiz, Merril Gersten, Mark Becker, James McNamara, Lynne M. Mofenson, Lynne M. Mofenson. Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors In Children Infected With Human Immunodeficiency Virus Type-1. New England Journal of Medicine. 1999. 341: 1874-81.Year
1999
Journal
New England Journal of Medicine
Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.
Citation
Ian Marschner, Rebecca Betensky, Victor DeGruttola, Scott M. Hammer, Daniel R. Kuritzkes. Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999. 20: 220-7.Year
1999
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl
Citation
Heather D. Watts, Catherine Spino, Larry Zaborski, David Katzenstein, Scott M. Hammer, Constance A. Benson. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999. 20: 455-62.Year
1999
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology